We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+12.64%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$136M
AUM Growth
+$13.2M
Cap. Flow
-$447K
Cap. Flow %
-0.33%
Top 10 Hldgs %
39.37%
Holding
81
New
13
Increased
17
Reduced
31
Closed
2

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.7M
2
STZ icon
Constellation Brands
STZ
+$1.09M
3
WGO icon
Winnebago Industries
WGO
+$700K
4
ALSN icon
Allison Transmission
ALSN
+$593K
5
DLX icon
Deluxe
DLX
+$583K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.3M
2
VZ icon
Verizon
VZ
+$1.19M
3
QCOM icon
Qualcomm
QCOM
+$1.09M
4
SHW icon
Sherwin-Williams
SHW
+$981K
5
XOM icon
ExxonMobil
XOM
+$903K

Sector Composition

Rank Sector Weight
1 Healthcare 22.42%
2 Financials 17.26%
3 Technology 16.65%
4 Industrials 12.95%
5 Consumer Staples 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
76
Amgen
AMGN
$203B
$70K 0.05%
+366
New +$69.9K
LLY icon
77
Eli Lilly
LLY
$1.07T
$14K 0.01%
+110
New +$13.4K
UNP icon
78
Union Pacific
UNP
$183B
$13K 0.01%
+75
New +$12.1K
QCOM icon
79
Qualcomm
QCOM
$176B
– –
-19,240
Closed -$1.09M
SHW icon
80
Sherwin-Williams
SHW
$78.3B
– –
-7,482
Closed -$981K
1 2 3
4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q1 2019 Portfolio in Review

As of Q1 2019, Lipe & Dalton held 81 positions worth $136M, up 11% from $123M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lipe & Dalton's Q1 2019 filing shows 13 new, 17 increased, 31 reduced and 2 closed positions. Its largest new stake was Constellation Brands: 6,485 shares worth $1.14M. The largest sale was Biogen, an estimated $1.3M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • Lipe & Dalton's largest Q1 2019 buy was Constellation Brands: 6,485 shares worth $1.14M.
  • Lipe & Dalton added most to AbbVie in Q1 2019, an estimated $1.7M increase.
  • Lipe & Dalton's biggest Q1 2019 reduction was Biogen, cutting an estimated $1.3M.
  • Lipe & Dalton fully exited Qualcomm in Q1 2019, selling an estimated $1.09M.
  • Lipe & Dalton's ten largest holdings make up 39% of its $136M portfolio in Q1 2019.
  • Lipe & Dalton opened 13 new positions and closed 2 in Q1 2019.
  • Lipe & Dalton's portfolio value rose 11% quarter-over-quarter to $136M.

Based on Lipe & Dalton's 13F filing for Q1 2019, filed 30 Apr 2019.